Literature DB >> 1656001

An improved radionuclide technique for the detection of altered pulmonary permeability.

P Monaghan1, I Provan, C Murray, D W Mackey, H Van der Wall, B M Walker, P D Jones.   

Abstract

Technegas, an ultra-fine dry aerosol with prolonged retention in the lungs, can be modified by altering the atmosphere in which the carbon particles are generated. The modified Technegas has much faster clearance from the lung. The half-time pulmonary clearances with modified Technegas were compared to those obtained with conventional 99mTc DTPA aerosol in 50 patients. Interstitial lung disease was suspected in 12 while 38 were infected with the human immunodeficiency virus and suspected of having opportunistic lung infection. In 22 nonsmokers in whom no evidence of active pulmonary pathology was demonstrable, the mean half-time with DTPA was 52.5 min whereas the mean half-time with modified aerosol was 10.1 min. The mean half-time in 14 smokers in whom there was also no evidence of active pulmonary disease was 28.3 min with DTPA and 7.0 min with the modified method. In the 14 patients in whom altered pulmonary permeability was demonstrated by a short DTPA half-time (mean 4.8 min) there was also an accelerated half-time with modified Technegas (mean 2.5 min). It is concluded that the modified Technegas procedure offers a simple but accurate method of identifying individuals having opportunistic infection or other diffuse lung pathology.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656001

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Site of deposition and absorption of an inhaled hydrophilic solute.

Authors:  Eva Bondesson; Thomas Bengtsson; Lars-Erik Nilsson; Per Wollmer
Journal:  Br J Clin Pharmacol       Date:  2007-01-23       Impact factor: 4.335

2.  Technegas and Pertechnegas particle size distribution.

Authors:  J J Lloyd; R A Shields; C J Taylor; R S Lawson; J M James; H J Testra
Journal:  Eur J Nucl Med       Date:  1995-05

3.  Ventilation/Perfusion Relationships and Gas Exchange: Measurement Approaches.

Authors:  Susan R Hopkins
Journal:  Compr Physiol       Date:  2020-07-08       Impact factor: 9.090

Review 4.  Radiopharmaceutical Labelling for Lung Ventilation/Perfusion PET/CT Imaging: A Review of Production and Optimization Processes for Clinical Use.

Authors:  Frédérique Blanc-Béguin; Simon Hennebicq; Philippe Robin; Raphaël Tripier; Pierre-Yves Salaün; Pierre-Yves Le Roux
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

5.  Evaluation of lung clearance of inhaled pertechnegas.

Authors:  S Fanti; G Compagnone; D Pancaldi; R Franchi; C Corbelli; M Marengo; C Onofri; R Galassi; M Levorato; N Monetti
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

6.  An evaluation of Technegas as a ventilation agent compared with krypton-81 m in the scintigraphic diagnosis of pulmonary embolism.

Authors:  G Cook; S E Clarke
Journal:  Eur J Nucl Med       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.